WAVE Life Sciences Ltd. | Mutual Funds
Mutual Funds that own WAVE Life Sciences Ltd.
BB Biotech AG
896,096
3.06%
896,096
1.14%
03/31/2018
Fidelity Select Biotechnology Portfolio
684,212
2.33%
-25,000
0.4%
07/31/2018
T Rowe Price Small Cap Stock Fund
499,957
1.71%
-3,000
0.25%
06/30/2018
Janus Global Life Sciences Fund
482,507
1.65%
72,664
0.63%
06/30/2018
iShares Russell 2000 ETF
368,776
1.26%
-198
0.04%
09/06/2018
Janus Venture Fund
287,582
0.98%
0
0.42%
06/30/2018
T Rowe Price Health Sciences Fund
279,200
0.95%
-5,698
0.12%
06/30/2018
T Rowe Price Institutional Small Cap Stock Fund
239,833
0.82%
0
0.26%
06/30/2018
Wells Fargo Advantage Discovery Fund
238,300
0.81%
0
0.4%
07/31/2018
T Rowe Price New Horizons Fund
215,378
0.74%
215,378
0.05%
06/30/2018
| Address |
Marina One East Tower
Singapore CE 018936
Singapore
|
|
Employees
|
- |
| Website |
http://www.wavelifesciences.com |
| Updated |
07/08/2019 |
| Wave Life Sciences Ltd. is a biotechnology company, which engages in the development of proprietary synthetic chemistry drug. It focuses on the design, development, and commercialization of nucleic acid-based therapeutics. The company was founded by Gregory L. |
